Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Leucovorin × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 10 Other hematologic neoplasm 2 Lymphoid 2 CNS 2 Other solid neoplasm 1 Gastrointestinal 1 Dermatologic 1

Conditions

Melanoma 7 Neoplasm Metastasis 4 Carcinoma, Renal Cell 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Pancreatic Neoplasms 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Sezary Syndrome 2 Ovarian Neoplasms 2 Mycosis Fungoides 2 Lymphoma, Large-Cell, Anaplastic 2 Lung Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Basal Cell 1 Neoplasms 1 Multiple Myeloma 1 Mesothelioma, Malignant 1

Interventions

Cyclophosphamide 16 pembrolizumab 14 Radiosurgery 7 Nivolumab 5 Celecoxib 5 poly ICLC 4 Radiation 4 Injections 4 Radiotherapy 3 Melphalan 3 Ipilimumab 3 Filgrastim 3 Etoposide 3 Docetaxel 3 Cryosurgery 3 Blood Specimen Collection 3 Biopsy 3 130-nm albumin-bound paclitaxel 3 trastuzumab deruxtecan 2 tislelizumab 2 talimogene laherparepvec 2 spartalizumab 2 fludarabine phosphate 2 fludarabine 2 durvalumab 2 cemiplimab 2 atezolizumab 2 aldesleukin 2 Transurethral Resection of Prostate 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03009058 2024-11-25

MODULATE

Immodulon Therapeutics Ltd

Phase 1/2 Terminated

2 enrolled 7 charts

DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡